Can a child with G6PD deficiency who has a mild cough receive the measles‑rubella (MMR) vaccine?

Yes, vaccinate the child with MMR vaccine

A child with G6PD deficiency who has a mild cough can and should receive the measles-rubella (MMR) vaccine. Neither G6PD deficiency nor mild respiratory symptoms are contraindications to MMR vaccination.

G6PD Deficiency and MMR Vaccination

G6PD deficiency is not a contraindication to MMR vaccination. The comprehensive Clinical Pharmacogenetics Implementation Consortium guideline on G6PD deficiency 1 does not list MMR vaccine as a high, medium, or even low-risk medication for patients with G6PD deficiency. The FDA drug label for MMR vaccine 2 does not mention G6PD deficiency as a contraindication or precaution.

• The only documented vaccine-related hemolytic event in G6PD deficiency involved pneumococcal vaccination 3, not MMR
• MMR is a live viral vaccine that does not contain oxidative agents that trigger hemolysis in G6PD deficiency
• No evidence exists linking MMR vaccination to hemolytic crises in G6PD-deficient individuals

Mild Cough and MMR Vaccination

Minor illnesses with or without fever, including upper respiratory infections, are NOT contraindications to MMR vaccination 4. The ACIP guidelines explicitly state that vaccination should not be postponed for minor illnesses 4.

Evidence Supporting Vaccination During Mild Illness:

• Seroconversion rates are equivalent: Children with upper respiratory infections achieve 99% measles seroconversion vs. 97% in well children 5
• Antibody responses are identical: The magnitude of antibody response to measles, mumps, and rubella antigens is the same in children with and without mild illness 5
• No increased adverse events: Mild illness does not increase rates or severity of post-vaccination adverse events 5
• Afebrile URI has no effect: Upper respiratory infection during the 28 days before, at the time of, or up to 7 days after immunization does not affect antibody response 6

When to Defer Vaccination

The only illness-related reason to postpone MMR vaccination is moderate or severe febrile illness 4. This deferral is to:

• Avoid superimposing vaccine adverse effects on the underlying illness
• Prevent mistakenly attributing manifestations of the illness to the vaccine

Common Pitfall to Avoid:

Do not perform routine physical examinations or measure temperatures as prerequisites for vaccinating children who appear in good health 4. Simply ask the parent if the child has moderate or severe illness. A mild cough alone does not constitute moderate or severe illness.

Actual Contraindications to MMR

The FDA label 2 lists true contraindications:

• Severe immunosuppression (not G6PD deficiency)
• Pregnancy
• Severe allergic reaction to vaccine components (including gelatin)
• Active untreated tuberculosis
• Fever (but not mild respiratory symptoms without significant fever)

Clinical Algorithm

1. Ask about fever: If no fever or only low-grade fever → proceed with vaccination
2. Assess severity of illness: Mild cough/URI → proceed; moderate/severe febrile illness → defer
3. Check for true contraindications: Severe immunosuppression, pregnancy, allergies, active TB
4. G6PD status: Does not affect decision to vaccinate with MMR

Bottom line: Vaccinate this child now. Delaying vaccination unnecessarily increases the window of susceptibility to measles, which carries significant morbidity and mortality risk, especially given recent measles outbreaks 7. The effectiveness of MMR in preventing measles is 95% after one dose and 96% after two doses 8, far outweighing any theoretical concerns about mild concurrent illness or G6PD deficiency.